Αποτελέσματα Αναζήτησης
14 Ιαν 2011 · This paper reviews the incidence, pathogenetic mechanisms and management strategies of diabetes mellitus in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS).
1 Νοε 2023 · Diabetes in People Living with HIV. Sudipa Sarkar, MD, MSCI and Todd T. Brown, MD, PhD. Author Information and Affiliations. Last Update: November 1, 2023. ABSTRACT. People living with HIV (PLWH) are living longer and also have unique risk factors for developing several metabolic diseases, including diabetes.
13 Οκτ 2014 · This review covers the epidemiology of DM in HIV-infected patients, and diagnosis, management, and treatment goals for DM in HIV-infected patients. We highlight the most recent DM treatment guidelines from the American Diabetes Association and the European Association for the Study of Diabetes, emphasizing individualization of DM medication ...
22 Αυγ 2023 · Patients with diabetes should strive for an HbA1c of 7%, which is equivalent to a mean blood glucose level of 152 mg/dL (8.4 mmol/L), fasting and preprandial readings of 129 mg/dL (7.4 mmol/L), and postprandial level of 185 mg/dL (10.2 mmol/L) . Since HbA1c tends to underestimate hyperglycemia in HIV patients, healthcare providers caring for ...
17 Μαρ 2021 · To discuss the diagnosis, treatment, and complications of diabetes in people with HIV (PWH) and to review HIV-related factors that may contribute to the development of diabetes or alter decisions in the care and treatment of PWH with diabetes.
11 Ιαν 2023 · Sixty-three percent had LDL <100 mg/dl (25% had LDL <70 mg/dl). Eighteen (9%) out of the 200 PLWH with a confirmed diagnosis of DM were treated only with diet and physical activity (versus 5.4% in HIV-negative DM patients); the remaining were mainly treated with metformin (53.8%) or insulin (20.9%) monotherapies.
17 Μαρ 2021 · Purpose of review: To discuss the diagnosis, treatment, and complications of diabetes in people with HIV (PWH) and to review HIV-related factors that may contribute to the development of diabetes or alter decisions in the care and treatment of PWH with diabetes.
